Abstract
Advancements in Early Diagnosis of Rheumatoid Arthritis: A Shift Toward Precision Medicine
Author(s): Yves Renaudineau*Rheumatoid arthritis (RA) is a chronic autoimmune disorder that leads to joint inflammation, pain, and potential long-term disability. Early diagnosis is crucial for preventing irreversible joint damage, yet identifying RA in its early stages has been a significant challenge due to nonspecific symptoms and limited diagnostic tools. Recent advancements in precision medicine are transforming the landscape of RA diagnosis, utilizing genetic insights, novel biomarkers, advanced imaging techniques, and artificial intelligence (AI) to detect the disease earlier and more accurately. This shift toward precision medicine allows for personalized treatment strategies, improving patient outcomes and minimizing side effects. By combining genetic, clinical, and environmental data, precision medicine facilitates targeted interventions that can prevent disease progression. This article reviews the latest innovations in RA diagnosis, highlights the role of precision medicine, and discusses the future directions for early detection and personalized care in RA management.